The effect of moderate alcohol consumption on fat distribution and adipocytokines

Obesity

Volumn 14, Issue 1, 2006, Pages 60-66

  Beulens, Joline W J ^a,b   Van Beers, Roderik M ^a   Stolk, Ronald P ^c,d   Schaafsma, Gertjan ^a,b   Hendriks, Henk F J ^a  

^a TNO   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Abdominal obesity; Adiponectin; Insulin sensitivity; Resistin; Ultrasound

Indexed keywords

ADIPONECTIN; INSULIN; RESISTIN;

ABDOMINAL FAT; ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD; BODY COMPOSITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRINKING BEHAVIOR; HUMAN; MALE; METABOLISM; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL; SECRETION;

ABDOMINAL FAT; ADIPONECTIN; ADIPOSE TISSUE; ADULT; AGED; ALCOHOL DRINKING; BODY COMPOSITION; CROSS-OVER STUDIES; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; RESISTIN; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 33746807808     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2006.8     Document Type: Article

References (38)

1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-8.
2. Hu G, Qiao Q, Tuomilehto J, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004; 164:1066-76.
3. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: The San Antonio Heart Study. Diabetes Care. 2003;26: 3153-9.
4. Grobbee DE, Rimm EB, Keil U, Renaud S. Alcohol and the cardiovascular system. In: MacDonald I, ed. Health Issues Related to Alcohol Consumption. Oxford, United Kingdom: Blackwell Publishing Ltd.; 1999, pp. 125-79.
5. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005;28:719-25.
6. Beulens JW, Sierksma A, van Toi A, et al. Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1. J Lipid Res. 2004;45:1716-23.
7. Davies MJ, Baer DJ, Judd JT, et al. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559-62.
8. Sierksma A, Patel H, Ouchi N, et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factoralpha, and insulin sensitivity. Diabetes Care. 2004;27:184-9.
9. Djousse L, Arnett DK, Eckfeldt JH, et al. Alcohol consumption and metabolic syndrome: does the type of beverage matter? Obes Res. 2004; 12:1375-85.
10. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087-94.
11. Macdonald I, Derby G, Westerterp K. Alcohol and Overweight: Health Issues Related to Alcohol Consumption. Brussels, Belgium: ILSI Europe; 1993, pp. 263-79.
12. Bell RA, Mayer-Davis EJ, Martin MA, D'Agostino RB Jr, Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care. 2000;23:1630-6.
13. Kiechl S, Willeit J, Poewe W, et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ. 1996;313: 1040-4.
14. Cordain L, Bryan ED, Melby CL, Smith MJ. Influence of moderate daily wine consumption on body weight regulation and metabolism in healthy free-living males. J Am Coll Nutr. 1997;16:134-9.
15. Cordain L, Melby CL, Hamamoto AE, et al. Influence of moderate chronic wine consumption on insulin sensitivity and other correlates of syndrome X in moderately obese women. Metabolism. 2000;49:1473-8.
16. Beltowski J. Adiponectin and resistin: new hormones of white adipose tissue. Med Sci Monit. 2003;9:RA55-61.
17. Stolk RP, Wink O, Zelissen PM, et al. Validity and reproducibility of ultrasonography for the measurement of intraabdominal adipose tissue. Int J Obes Relat Metab Disord. 2001;25:1346-51.
18. Whittaker AD, Park B, Thane BR, Miller RK, Savell JW. Principles of ultrasound and measurement of intramuscular fat. J Anim Sci. 1992;70:942-52.
19. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
20. van den Berg R, Haenen GRMM, Van den Berg H, Bast A. Applicability of an improved Trolox equivalent antioxidant capacity (TEAC) assay for evaluation of antioxidant capacity measurements of mixtures. Food Chem. 1999;66:511-7.
21. Hertog MG, Hollman PC, Venema DP. Optimization of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetable and fruits. J Agric Food Chem. 1992;40:1591-8.
22. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-23.
23. Liu S, Serdula MK, Williamson DF, Mokdad AH, Byers T. A prospective study of alcohol intake and change in body weight among US adults. Am J Epidemiol. 1994;140:912-20.
24. Dallongeville J, Marecaux N, Ducimetiere P, et al. Influence of alcohol consumption and various beverages on waist girth and waist-to-hip ratio in a sample of French men and women. Int J Obes Relat Metab Disord. 1998;22:1178-83.
25. Han TS, Bijnen FC, Lean ME, Seidell JC. Separate associations of waist and hip circumference with lifestyle factors. Int J Epidemiol. 1998;27:422-30.
26. Keenan NL, Strogatz DS, James SA, Ammerman AS, Rice BL. Distribution and correlates of waist-to-hip ratio in black adults: the Pitt County Study. Am J Epidemiol. 1992;135:678-84.
27. Koh-Banerjee P, Chu NF, Spiegelman D, et al. Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16,587 US men. Am J Clin Nutr. 2003;78:719-27.
28. Pischon T, Girman CJ, Rifai N, Hotamisligil GS, Rimm EB. Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr. 2005;81:780-6.
29. Shai I, Rimm EB, Schulze MB, et al. Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men. Diabetologia. 2004;47:1760-7.
30. Baratta R, Amato S, Degano C, et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab. 2004;89:2665-71.
31. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86: 3815-9.
32. Booyse FM, Aikens ML, Grenett HE. Endothelial cell fibrinolysis: transcriptional regulation of fibrinolytic protein gene expression (t-PA, u-PA, and PAI-1) by low alcohol. Alcohol Clin Exp Res. 1999;23:1119-24.
33. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-6.
34. Arky RA, Abramson EA, Freinkel N. Alcohol hypoglycemia: VII. Further studies on the refractoriness of obese subjects. Metabolism. 1968; 17:977-87.
35. Asensio C, Cettour-Rose P, Theander-Carrillo C, Rohner-Jeanrenaud F, Muzzin P. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Endocrinology. 2004; 145: 2206-13.
36. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res. 2002; 10:1-5.
37. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003;88:4848-56.
38. Azuma K, Katsukawa F, Oguchi S, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003; 11:997-1001.